RT Journal Article
SR Electronic
T1 Cortical abnormalities and identification for first-episode schizophrenia via high-resolution magnetic resonance imaging
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.05.20020768
DO 10.1101/2020.02.05.20020768
A1 Lin Liu
A1 Long-Biao Cui
A1 Xu-Sha Wu
A1 Ning-Bo Fei
A1 Zi-Liang Xu
A1 Di Wu
A1 Yi-Bin Xi
A1 Peng Huang
A1 Karen M. von Deneen
A1 Shun Qi
A1 Ya-Hong Zhang
A1 Hua-Ning Wang
A1 Hong Yin
A1 Wei Qin
YR 2020
UL http://medrxiv.org/content/early/2020/02/07/2020.02.05.20020768.1.abstract
AB Intro Evidence from neuroimaging has implicated abnormal cerebral cortical patterns in schizophrenia. Application of machine learning techniques is required for identifying structural signature reflecting neurobiological substrates of schizophrenia at the individual level. We aimed to detect and develop a method for potential marker to identify schizophrenia via the features of cerebral cortex using high-resolution magnetic resonance imaging (MRI).Method In this study, cortical features were measured, including volumetric (cortical thickness, surface area, and gray matter volume) and geometric (mean curvature, metric distortion, and sulcal depth) features. Patients with first-episode schizophrenia (n = 52) and healthy controls (n = 66) were included from the Department of Psychiatry at Xijing Hospital. Multivariate computation was used to examine the abnormalities of cortical features in schizophrenia. Features were selected by least absolute shrinkage and selection operator (LASSO) method. The diagnostic capacity of multi-dimensional neuroanatomical patterns-based classification was evaluated based on diagnostic tests.Results Mean curvature (left insula and left inferior frontal gyrus), cortical thickness (left fusiform gyrus), and metric distortion (left cuneus and right superior temporal gyrus) revealed both group differences and diagnostic capacity. Area under receiver operating characteristic curve was 0.88, and the sensitivity, specificity, and accuracy of were 94%, 82%, and 88%, respectively. Confirming these findings, similar results were observed in the independent validation. There was a positive association between index score derived from the multi-dimensional patterns and the severity of symptoms (r = 0.40, P < .01) for patients.Discussion Our findings demonstrate a view of cortical differences with capacity to discriminate between patients with schizophrenia and healthy population. Structural neuroimaging-based measurements hold great promise of paving the road for their clinical utility in schizophrenia.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Basic Research Program of China under Grant Nos. 2015CB856403 and 2014CB543203, the Science and Technology Projects of Xi’an, China under Grant 201809170CX11JC12, and the National Natural Science Foundation of China under Grant Nos. 81771918, 81471811, and 81471738, the Fundamental Research Funds for the Central Universities (Dr Qin), grant 81801675 from the National Natural Science Foundation of China, grant 2019TQ0130 from Project funded by China Postdoctoral Science Foundation, and grant support 2019CYJH of Fourth Military Medical University (Dr Cui), grants 2017ZDXM-SF-048 from the Key Research and Development Program of Shaanxi Province and 81571651 from the National Natural Science Foundation of China (Dr Yin), and grant 81601456 from the National Natural Science Foundation of China (Dr Qi).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated for this study are available on request to the corresponding author.